(Total Views: 355)
Posted On: 09/04/2020 12:05:47 PM
Post# of 56
$LXRX News Article - Lexicon Pharmaceuticals Announces Commencement of Patient Dosing in RELIEF-DPN-1 Phase 2 Clinical Study of LX9211 in Patients With Diabetic Peripheral Neuropathic Pain https://marketwirenews.com/news-releases/lexi...96517.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
